These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22849739)

  • 21. [Carcinoma and oncocytoma of the kidney. Phenotypic characteristics and prognostic features].
    Störkel S
    Veroff Pathol; 1993; 140():1-165. PubMed ID: 8434485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
    Chang A; Brimo F; Montgomery EA; Epstein JI
    Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas.
    Calderaro J; Masliah-Planchon J; Richer W; Maillot L; Maille P; Mansuy L; Bastien C; de la Taille A; Boussion H; Charpy C; Jourdain A; Bléchet C; Pierron G; Gentien D; Choudat L; Tournigand C; Delattre O; Allory Y; Bourdeaut F
    Eur Urol; 2016 Jun; 69(6):1055-61. PubMed ID: 26433572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
    Chen CY; Liao YM; Tsai WM; Kuo HC
    J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INI1-deficient tumors: diagnostic features and molecular genetics.
    Hollmann TJ; Hornick JL
    Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.
    Gonzalez-Roibon N; Faraj SF; Munari E; Bezerra SM; Albadine R; Sharma R; Argani P; Allaf ME; Netto GJ
    Hum Pathol; 2014 Feb; 45(2):244-8. PubMed ID: 24315206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid papillary renal cell carcinoma: clinicopathologic, morphologic, and immunohistochemical analysis of 10 cases and review of the literature.
    Ulamec M; Skenderi F; Trpkov K; Kruslin B; Vranic S; Bulimbasic S; Trivunic S; Montiel DP; Peckova K; Pivovarcikova K; Ondic O; Daum O; Rotterova P; Dusek M; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2016 Aug; 23():51-7. PubMed ID: 27209513
    [No Abstract]   [Full Text] [Related]  

  • 28. Asynchronous collecting duct carcinoma of the kidney and pulmonary adenocarcinoma. A case report.
    Okoń K; Demczuk S; Dobrowolska B; Kaznowska E; Dobrowolski Z; Stachura J
    Pol J Pathol; 2002; 53(4):229-34. PubMed ID: 12597341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics.
    Pramick M; Ziober A; Bing Z
    Ann Diagn Pathol; 2013 Oct; 17(5):437-40. PubMed ID: 23791764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas.
    Shirakawa H; Kikuchi E; Mikami S; Fukamachi S; Miyazaki Y; Tanaka N; Miyajima A; Oya M
    Scand J Urol Nephrol; 2012 Apr; 46(2):136-41. PubMed ID: 22251056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of lung resistance-related protein in lower grade urothelial carcinoma of the renal pelvis and ureter.
    Kong CZ; Zeng Y; Wu XX; Li JQ; Zhu YY; Chen Y
    Int J Urol; 2004 Sep; 11(9):721-7. PubMed ID: 15379935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
    Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
    Agaimy A
    Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Differential Diagnosis of Medullary-Based Renal Masses.
    Baniak N; Tsai H; Hirsch MS
    Arch Pathol Lab Med; 2021 Sep; 145(9):1148-1170. PubMed ID: 33406251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of uroplakin II expression as a marker of urothelial carcinoma.
    Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
    Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of vimentin and high-molecular-weight cytokeratin (clone 34ßE12) in differentiating reactive renal tubular cells from low-grade urothelial carcinoma cells in voided urine.
    Ohsaki H; Hirakawa E; Nakamura M; Norimatsu Y; Kiyomoto H; Haba R
    Cytopathology; 2011 Aug; 22(4):247-52. PubMed ID: 20653719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different immunohistochemical patterns of Fhit protein expression in renal neoplasms.
    Eyzaguirre EJ; Miettinen M; Norris BA; Gatalica Z
    Mod Pathol; 1999 Oct; 12(10):979-83. PubMed ID: 10530564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.
    Hoang LL; Tacha D; Bremer RE; Haas TS; Cheng L
    Appl Immunohistochem Mol Morphol; 2015; 23(10):711-6. PubMed ID: 25611245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
    Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
    Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.